ATAD1 Overexpression Enhances Mitochondrial and Peroxisomal Function in Zellweger Syndrome Disorder Models
Diego BaronioiD, Tamara J. Stevenson, Courtney E. Demmitt-Rice, Esther NuebeliD, Amanda Mixon BlackwelliD, Joshua L. BonkowskyiD
Abstract
Zellweger Spectrum Disorders (ZSDs) are caused by mutations in any of the different peroxin (PEX) genes, which are essential for peroxisome biogenesis and function. Clinical features of ZSDs include seizures, leukodystrophy, renal and liver dysfunction, skeletal abnormalities, and they usually result in death during infancy or early childhood. There are no treatments for ZSDs, and their rarity, the large size of the PEX genes, and the numerous different genes, has impaired therapeutic development. We previously demonstrated that ATAD1, a mitochondrial protein quality control chaperone, could correct both mitochondrial and peroxisomal phenotypes in PEX3 patient fibroblasts. In this study, we investigated whether overexpressing ATAD1 could provide similar benefits in PEX1 and PEX6 patient cell lines, which account for over 70% of ZSD cases. We used established PEX6-/- HEK293 cells, patient-derived fibroblasts with pathogenic PEX1 mutations, and newly created zebrafish mutants. Lipidomic profiling of the cell lines demonstrated widespread dysregulation, including accumulation of lysophosphatidylcholines with very-long-chain fatty acids, depletion of plasmalogens and cholesteryl esters containing polyunsaturated fatty acids, and a decrease in cardiolipins. Overexpressing ATAD1 partly corrected these imbalances, including normalizing VLCFA metabolism in PEX1 fibroblasts and restoring plasmalogens and cardiolipins in PEX6-deficient cells. Mitochondrial function analysis (Seahorse XF) showed that ATAD1 increased basal and ATP-linked respiration in both PEX1- and PEX6-deficient cells, sometimes surpassing the effects of PEX gene re-expression. ATAD1 increased peroxisome numbers in both PEX6 and PEX1 cells. Zebrafish Pex1 mutants exhibited impaired maximal respiration despite normal basal activity, confirming mitochondrial vulnerability in vivo. These findings further confirm a role for ATAD1 as a modifier that improves lipid metabolism, mitochondrial function, and peroxisome abundance that could function across multiple ZSDs.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Msp1/ATAD1 restores mitochondrial function in Zellweger Spectrum Disease
E. Nuebel, J. T. Morgan, … J. Rutter·bioRxiv·Sep 19, 2020
- Longitudinal study of liver disease progression in the PEX1-Gly844Asp mouse model of mild Zellweger Spectrum Disorder
Lingxiao Chen, Hong Yul Choi, … Nancy Braverman·bioRxiv·May 8, 2025
- Geographic characterization of RPE structure and lipid changes in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorder.
Samy Omri, Catherine Argyriou, … Nancy Braverman·Journal of Lipid ResearchPeer-reviewed·Mar 7, 2025
- Zebrafish model of human Zellweger syndrome reveals organ specific accumulation of distinct fatty acid species and widespread gene expression changes
Shigeo Takashima, Shoko Takemoto, … Nobuyuki Shimozawa·Molecular Genetics and MetabolismPeer-reviewed·May 8, 2021
- Modeling the cell biology of PEX11β deficiency during human neurogenesis
Caroline Bodnya, Rensu P. Theart, Vivian Gama·bioRxiv·Feb 16, 2026
- Drosophila Models Uncover Substrate Channeling Effects on Phospholipids and Sphingolipids in Peroxisomal Biogenesis Disorders
Michael F. Wangler, Yu-Hsin Chao, … James A. McNew·PLoS ONEPeer-reviewed·Jun 11, 2025